Measuring the Prevalence of Diagnosed Chronic Obstructive Pulmonary Disease in the United States Using Data From the 2012-2014 National Health Interview Survey
Measuring the Prevalence of Diagnosed Chronic Obstructive Pulmonary Disease in the United States Using Data From the 2012-2014 National Health Interview Survey
复制标题
DOI：
10.1177/0033354916688197
复制
发表时间：
2017-03-01
影响因子：
3.3
通讯作者：
Vahratian, Anjel
中科院分区：
文献类型：
--
作者：
Ward, Brian W.;Nugent, Colleen N.;Vahratian, Anjel
诊断为呼吸系统疾病（如肺气肿、慢性支气管炎和/或慢性阻塞性肺病）。目的：本研究测量慢性阻塞性肺疾病（COPD）的患病率，检查(1)明确询问诊断为COPD的单一调查问题是否足以识别美国成人COPD患者；(2)该测量与使用诊断为肺气肿和/或慢性支气管炎的调查问题以及所有3个调查问题一起估计COPD患病率的方法如何比较。方法：我们使用2012-2014年全国健康访谈调查的数据来检查7211名报告了以下情况的美国成年人的不同患病率测量方法：结果：我们通过使用包含所有3种诊断的测量方法（6.1%;95% CI, 5.9%-6.3%）估计COPD的患病率明显高于仅使用COPD诊断的测量方法（3.0%;95% CI, 2.8%-3.1%）或肺气肿和/或慢性支气管炎诊断的测量方法（4.7%;95% CI, 4.6%-4.9%）。这种模式在除非西班牙裔亚裔成年人外的所有亚组中都很显著。在某些亚组（18-39岁的成年人、西班牙裔成年人和从不吸烟者）中，COPD测量值之间的百分比差异更大；进一步的分析表明，这种差异是由于这些亚组中有很大比例的成年人仅报告慢性支气管炎的诊断。结论：使用自我或患者报告的健康调查数据，如全国健康访谈调查，建议仅询问受访者COPD诊断的措施不足以估计COPD的患病率。相反，考虑肺气肿、慢性支气管炎和/或COPD诊断的测量可能是更好的测量。额外的分析应该探讨与COPD相关的调查问题的可靠性和有效性，特别关注慢性支气管炎的问题。
diagnosed respiratory condition (ie, emphysema, chronic bronchitis, and/or COPD). Objectives: This study, measuring the prevalence of chronic obstructive pulmonary disease (COPD), examined (1) whether a single survey question asking explicitly about diagnosed COPD is sufficient to identify US adults with COPD and (2) how this measure compares with estimating COPD prevalence using survey questions on diagnosed emphysema and/or chronic bronchitis and all 3 survey questions together.Methods: We used data from the 2012-2014 National Health Interview Survey to examine different measures of prevalence among 7211 US adults who reported aResults: We estimated a significantly higher prevalence of COPD by using a measure accounting for all 3 diagnoses (6.1%; 95% CI, 5.9%-6.3%) than by using a measure of COPD diagnosis only (3.0%; 95% CI, 2.8%-3.1%) or a measure of emphysema and/or chronic bronchitis diagnoses (4.7%; 95% CI, 4.6%-4.9%). This pattern was significant among all subgroups examined except for non-Hispanic Asian adults. The percentage difference between measures of COPD was larger among certain subgroups (adults aged 18-39, Hispanic adults, and never smokers); additional analyses showed that this difference resulted from a large proportion of adults in these subgroups reporting a diagnosis of chronic bronchitis only.Conclusions: With the use of self- or patient-reported health survey data such as the National Health Interview Survey, it is recommended that a measure asking respondents only about COPD diagnosis is not adequate for estimating the prevalence of COPD. Instead, a measure accounting for diagnoses of emphysema, chronic bronchitis, and/or COPD may be a better measure. Additional analyses should explore the reliability and validation of survey questions related to COPD, with special attention toward questions on chronic bronchitis.